Dr. John William Jacobs Jr., MD

Dr. Jacobs practices at TGH Surgery Center at Morsani in Tampa, Florida.

Dr. Jacobs' NPI, 1669631834, was assigned on June 3, 2008. Dr. Jacobs graduated from University of Miami, Miller School of Medicine in 2008. Dr. Jacobs holds Florida license ME120457.

Dr. Jacobs' primary practice is TGH Surgery Center at Morsani, at 13330 Usf Laurel Dr, Mdh 2nd Floor, Tampa, FL 33612. The practice phone is (813) 396-2376.

Dr. Jacobs' primary practice is TGH Surgery Center at Morsani in Tampa, Florida. Dr. Jacobs is also affiliated with Tampa General Hospital. The medical group on file is USF Therapy Services. Dmand AI also links Dr. Jacobs to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jacobs practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Jacobs' primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Jacobs is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Jacobs' licenses on file in 3 states: Florida, Texas and Indiana.

Dmand AI lists acid reflux, chronic indigestion, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver, gastrointestinal bleeding and irritable bowel syndrome (IBS) among the conditions Dr. Jacobs treats.

CMS data shows 844 Medicare services from Dr. Jacobs across 15 procedure codes in 2024, for 432 Medicare patients. Medicare paid $108,098 for them.

CMS counts 432 Medicare patients who saw Dr. Jacobs in 2024. The largest group is 65 to 74, with 195 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jacobs' median patient age at 62, with 55% women.

In 2024, Dr. Jacobs wrote 248 Medicare Part D claims for 82 patients. 90% of them were for generic drugs. CMS names the drug for 177 of them, across 6 drugs with 11 or more claims each, at $8,068 in total drug cost. In 2023, CMS named 119 claims across 5 drugs.

Dr. Jacobs accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Jacobs as offering telehealth. CMS counts 170 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Jacobs, more than 87% of the clinicians it reports for that procedure.

Dmand AI links 19 papers to Dr. Jacobs, published from 2014 to 2024. 2019 was the busiest year, with 3. The most frequent topics are Deglutition Disorders, Esophageal Achalasia and Esophageal Diseases. Dr. Jacobs has published most often in Am J Gastroenterol. Dr. Jacobs' most frequent co-authors are Joel Edward Richter, MD, Vic Velanovich, MD and Adham R. Saad, MD.

CMS Open Payments shows 137 general payments to Dr. Jacobs from 14 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 80% of the total. Sanofi and Genzyme US Companies paid the most, $109,493.

Dr. Jacobs graduated from University of Miami, Miller School of Medicine in 2008.

Dr. Jacobs is in network with 19 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.